Trials / Completed
CompletedNCT03763799
Early Stop(Ruling) of the Antibiotic Treatment During Pneumopathies d' Inhalation
Impact of a Strategy Based on the Unyvero® Testing System on Appropriate Antimicrobial Treatment in Patients With Suspected Aspiration Pneumonia Requiring Mechanical Ventilation : a Randomized Controlled Unblinded Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 266 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The two most common consequences resulting from aspiration are chemical pneumonitis and bacterial aspiration pneumonia. Both entities present with comparable clinical signs and symptoms. In the absence of a reliable clinical or biological marker to differentiate between these two conditions, most patients with suspected aspiration are treated empirically with antibiotics. De-escalation of initial antibiotic treatment is encouraged based on the results of microbiological results, usually performed before starting antimicrobial treatment. However, in most hospitals, 48-72h are required to obtain the results of microbiological cultures, and to de-escalate empirical large spectrum antibiotic treatment. The use of the Unyvero®, a multiplex PCR-based testing system, for detection of respiratory bacterial pathogens would allow decreasing the percentage of patients with aspiration syndrome who will receive unappropriated antibiotic treatment at Day 3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PCR-based microbiological diagnosis strategy | A multiplex PCR-based testing, will be used in addition to standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation |
| PROCEDURE | Standard microbiological diagnosis strategy | Standard strategy will be based on with standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation |
Timeline
- Start date
- 2019-09-20
- Primary completion
- 2024-02-22
- Completion
- 2024-02-22
- First posted
- 2018-12-04
- Last updated
- 2025-12-23
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03763799. Inclusion in this directory is not an endorsement.